Antisense nucleic acids have been used successfully to inhibit specifically the expression of cellular genes (for reviews, see references 22, 24, and 25) . Viral gene expression or other essential steps in the viral life cycle can also be affected by antisense nucleic acids (20, 28) . This has been demonstrated for procaryotic viruses (7) as well as for eucaryotic viruses including retroviruses. Thus, replication of the Rous sarcoma virus was partially suppressed by antisense RNA expressed from eucaryotic vectors (6, 23) , and the replication of human immunodeficiency virus type 1 (HIV-1) could be reduced by antisense oligodeoxyribonucleotides (1, 9) , chemically modified antisense oligodeoxyribonucleotides (5, 10, 21, 27) , and chemically modified antisense oligoribonucleotides (19) added to the culture medium.
In contrast to antisense oligonucleotides being applied extracellularly, intracellularly expressed antisense RNA is a potential antiviral agent which might be used for the development of "intracellular immunization" against virus infection (2) . This is also indicated by the finding that HIV-1 replication can be inhibited temporarily when infectious proviral HIV-1 DNA is comicroinjected with an HIV-1 antisense RNA expression plasmid into human cells (18) .
In this work, we show that HIV-1 replication is reduced in human T-cell lines constitutively expressing HIV-1 antisense RNA targeted against 407 bp of the 5' leader-gag region.
This result indicates that intracellularly expressed antisense RNA is a potential anti-HIV-1 agent. Expression vectors. The expression plasmid pKEX-1, as well as the plasmid vectors p2as and p2s designed for the expression of HIV-1 antisense and sense RNA, respectively (Fig. 1A) have been described elsewhere (18) . Briefly, constitutive transcription is directed by the human cytomegalovirus immediate-early promoter-enhancer element (4). The HIV-1 fragment expressed in p2as and p2s was derived from the HIV-1 proviral clone pBH1O (14) as a 407-bp SaclHindIII fragment (positions 222 to 629) covering 112 nucleotides of the 5' leader and 295 nucleotides coding for the gag 5' region. This sequence also includes the first splice donor, which is used in all known spliced HIV-1 transcripts (11, 17) . The resulting transcripts are terminated by 3'-processing signals from the simian virus 40 early region (12) and have a total expected length of 1,120 nucleotides. Additionally, the * Corresponding author.
hygromycin B resistance gene (3) , in cis on all plasmids, serves as a dominant selection marker.
Cell lines with constitutive antisense-sense RNA expression. The human CD4+ T-lymphoid cell line Jurkat (16, 26) was used as a tissue culture model system for measuring the effects of intracellular HIV-1 antisense RNA expression on HIV-1 replication. For the generation of stably transfected clones, Jurkat cells were electroporated in the presence of one of the plasmids pKEX-1, p2as, and p2s under conditions essentially as described previously (8) except for the initial voltage (250 V). Under hygromycin B selection (500 pLg/ml) in RPMI 1640 medium supplemented with 10% fetal calf serum, L-glutamine (2 mM), penicillin (100 U/ml), and streptomycin (100 jig/ml) at 37°C and 5% C02, resistant clones arose from total viable transfected cells with a frequency in the range of 5 x 10-6. The morphology of the stable Jurkat clones was indistinguishable from that of the parental cells, and all cell lines exhibited the same proliferation rate. The expression levels of the T-cell-specific surface antigens OKT4a, OKT4, and OKT8 as measured by radioimmunoassay also were indistinguishable for the parental cell line Jurkat, one representative (i.e., inhibitory) p2as clone, and one p2s clone.
The Jurkat clones were analyzed for the status of the transfected recombinant plasmid DNAs by restriction of chromosomal DNA and subsequent Southern hybridization with 32P-labeled plasmid DNA. Approximately 90% (25 of 28) transfectants analyzed integrated the plasmid DNA into their chromosome as a single copy. In most cases, this occurred without rearrangements in regard to the expression cassette for antisense and sense transcription, which is shown for four representative p2as and p2s clones in Fig. 1B . Northern (RNA) hybridization of total cytoplasmic RNAs from 14 independent clones which had been positive for integrated plasmid DNA showed detectable amounts of HIV-1 sequence containing transcripts in 9 cases (64%). The apparent size of p2as-derived HIV-1 antisense transcripts on Northern blots (Fig. 1C ) was approximately 50 nucleotides greater than that of the sense RNA transcribed from p2s, and also, the antisense transcripts appeared to be less abundant.
HIV-1 replication in antisense RNA-expressing cells. Since clonal variation was expected in the course of HIV-1 infection of different cell clones, to exclude clonal differences unrelated to the antisense RNA expression, HIV-1 infection was investigated in a total number of 10 independent stable p2as transfectants and was compared with infection in 10 and 19') , and parental Jurkat cells (lane J). RNAs were separated by formaldehyde-agarose gel electrophoresis, blotted onto Gene Screen Plus membrane, and hybridized with 32P-labeled plasmid p2s under stringent conditions (hybridization and washing as described above). Hybridization signals at the same positions as shown here were seen with 32P-labeled strand-specific riboprobes, additionally distinguishing between the antisense and sense transcripts. As an internal probe for the relative amounts of RNA in each sample, the blot was hybridized with a human P-actin cDNA probe (bottom part of the figure).
independent Jurkat(pKEX-1) clones as well as eight independent Jurkat(p2s) clones.
Jurkat clones were infected with cell-free supernatants from HIV-1-infected human T-cell lines (H9 or Jurkat; HIV-1 strain HTLV-IIIB [13] ). Since the spread of HIV-1 in human T cells was to be measured, rather than the initial infection efficiency immediately after the addition of infectious virus to the cells, a low dose of infectivity was used.
The initial infectious dose generated approximately 1% HIV-1 antigen immunofluorescence-positive cells 10 During the first 14 days after infection, HIV-1 antigen concentrations in the culture supernatants from p2as clones were reduced in comparison with those of pKEX and p2s control clones, with a maximum of 65% reduction on day 10 postinfection (Fig. 2) . Two weeks after infection, control clones showed 50 to 80% immunofluorescence-positive cells and the HIV-1 antigen concentration in cell-free supernatants was in the range of 2 x 104 units (Fig. 3) clones showed an inhibition of virus release into the culture medium which was 88% on day 10 and 68% on day 14 postinfection in comparison with pKEX-1 clones (Fig. 3A  and B) . On day 14 postinfection, in p2as(RNA+) cultures there were 5% immunofluorescence-positive cells compared with 27% in pKEX-1 controls, which is a fivefold reduction (Fig. 3C ). Indirect immunofluorescence in this experiment could not be quantitated exactly on day 10 (Fig. 3) .
The inhibition of HIV-1 replication in human CD4+ cells by intracellular antisense RNA expression, although incomplete and with variations among different clones, suggests that antisense RNA could be used as an antiretroviral agent. Inhibition of HIV-1 replication had also been observed previously in a transient comicroinjection assay with the same antisense RNA expression plasmid p2as (18) .
The reason why HIV-1 antisense RNA-expressing cells are protected in early stages of HIV-1 infection (i.e., delay in spread of HIV-1 infection) but become infected in later stages with similar virus proliferation rates as in pKEX-1 clones is unknown. However, the fact that finally (2 weeks postinfection) p2as(RNA+) cultures were also infected was not due to reduced antisense RNA expression. Even after 3 weeks of HIV-1 infection, p2as(RNA+) cells (40 to 70% HIV-1 antigen immunofluorescence-positive cells) did not show a detectable difference in antisense RNA expression levels as measured by Northern analysis (data not shown).
The sense RNA expression vector (p2s) in stably transfected cells did not have an inhibitory effect on HIV-1 replication, whereas it inhibited HIV-1 replication to the same extent as did p2as when comicroinjected together with infectious proviral HIV-1 DNA into human cells (18) . This differential behavior of p2s might be due to differences of both test systems. In the transient comicroinjection assay with human epithelioid cells, probably other steps in the replication cycle of HIV-1 are affected, as in T cells with constitutive RNA expression, in which all steps of the viral life cycle involving single-stranded viral nucleic acids are potential targets. Recently, intracellular expression of ribozyme-containing RNAs has been used to inhibit HIV-1 replication in stably transfected CD4+ HeLa cells (15) . The inhibitory effect in this case (95 to 97.5%) was measured 7 days after HIV-1 infection and thus seems to be in a range of inhibition similar to that measured in this work for antisense RNA.
Future improvements in the antiviral activity of intracellularly expressed antisense RNA will involve prolongation of the inhibitory effect as well as increase of the antisense effect. The latter could be achieved by the use of more effective HIV-1 target regions and might be supported by ribozyme sequences inserted into antisense transcripts.
